ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer

NCT05368506 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped PI discretion

Conditions

Interventions

Sponsor

OHSU Knight Cancer Institute

Collaborators